期刊
DRUG DISCOVERY TODAY
卷 21, 期 5, 页码 740-765出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2016.01.006
关键词
-
资金
- Biomedical Research Council
- Joint Council Office, Agency for Science, Technology and Research (AstarSTAR), Singapore
Glycosylation of therapeutic proteins has a profound impact on their safety and efficacy. Many factors shape the glycosylation of biotherapeutics, ranging from expression systems and cell culture processes to downstream purification strategies. Various analytical technologies have been developed to address questions concerning different aspects of glycosylation. Informatics tools are also crucial for a systematic understanding of the glycosylation processes. Hence, an integrated approach is required to harness glycosylation for the production of optimal and consistent glycoprotein-based therapeutic drugs. Here, we review the latest developments and challenges in glycosylation analysis and control in the context of bioprocessing monoclonal antibodies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据